Payments to Acquire Property, Plant, and Equipment of CRESCENT BIOPHARMA, INC. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Dec 2024 was $0.
  • CRESCENT BIOPHARMA, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $919,000, a 9116% increase from 2024.
  • CRESCENT BIOPHARMA, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $9,972, a 53% decline from 2023.
  • CRESCENT BIOPHARMA, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $21,394, a 75% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $919,000 +$909,028 +9116% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $9,972 -$11,422 -53% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $21,394 -$62,797 -75% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $84,191 +$69,248 +463% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $14,943 -$53,564 -78% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2024 2023 FY
2020 $68,507 -$76,421 -53% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2023 2022 FY
2019 $144,928 +$19,310 +15% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022 2021 FY
2018 $125,618 -$168,489 -57% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021 2020 FY
2017 $294,107 -$410,095 -58% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $704,202 +$435,608 +162% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
2015 $268,594 +$55,991 +26% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2018 2017 FY
2014 $212,603 +$130,512 +159% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $82,091 -$234,089 -74% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $316,180 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY

CRESCENT BIOPHARMA, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 20 Sep 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $0 20 Sep 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q1 2024 $7,439 +$5,242 +239% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $2,197 -$38,324 -95% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $40,521 +$37,461 +1224% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $3,060 -$5,076 -62% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $8,136 -$31,402 -79% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021 2021 Q1
Q1 2019 $39,538 +$22,920 +138% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q1 2018 $16,618 -$46,351 -74% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $62,969 +$45,699 +265% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $17,270 +$14,931 +638% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q1 2015 $2,339 -$11,581 -83% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $13,920 +$7,096 +104% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q1 2013 $6,824 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.